IP Library Granted Patent US 8,979,724
Granted Patent B2
US 8,979,724 · App. 13/629,316 · Granted Mar 17, 2015

General medication disposal system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,979,724
App. No.
13/629,316
Granted
Mar 17, 2015
Kind
B2
Abstract

General medication disposal systems are provided. Aspects of the systems include devices having a sealable container dimensioned to accommodate a pharmaceutical composition; and an amount of an inactivating substance, e.g., granulated or pelletized activated carbon, present inside of the sealable container. Aspects of the invention further include methods of making and using the systems, as well as kits comprising the devices of the system.

Claims (26)

1. A device for use in disposing an amount of a pharmaceutical composition, the device comprising:

a re-sealable container configured as a pouch and dimensioned to accommodate the pharmaceutical composition; and

an amount of granulated or pelletized activated carbon present inside of the re-sealable container and contained in a liquid permeable enclosure fabricated from a liquid permeable material and present inside of the re-sealable container.

2. The device according to claim 1 , wherein the granulated or pelletized activated carbon comprises activated carbon particles ranging in size from 0.25 to 5.0 mm.

3. The device according to claim 1 , wherein the liquid permeable enclosure is a water permeable enclosure.

4. The device according to claim 1 , wherein the device further comprises an anti-abuse distressing agent.

5. The device according to claim 4 , wherein the anti-abuse distressing agent is combined with the granular activated carbon.

6. The device according to claim 4 , wherein the anti-abuse distressing agent is a bitter-tasting agent.

7. The device according to claim 1 , wherein the amount of granulated activated carbon is selected to be more than theoretically required to substantially inactivate the amount of pharmaceutical composition for which the device has been configured.

8. The device according to claim 1 , wherein the container further comprises an excipient.

9. The device according to claim 8 , wherein the excipient comprises a salt.

10. The device according to claim 9 , wherein the salt is a salt of a divalent metal cation.

11. The device according to claim 10 , wherein the divalent metal cation is selected from the group consisting of Ca 2+ and Mg 2+ .

12. The device according to claim 1 , wherein the container comprises a vent.

13. The device according to claim 12 , wherein the vent is a one-way gas vent.

14. The device according to claim 1 , wherein the container further comprises an amount of a liquid.

15. The device according to claim 14 , wherein the liquid is an aqueous liquid.

16. The device according to claim 1 , wherein the device comprises a suspending agent.

17. The device according to claim 1 , wherein the liquid permeable enclosure is joined to the container.

18. A method of disposing an amount of a pharmaceutical composition, the method comprising:

placing the amount of the pharmaceutical composition into a sealable container comprising an amount of granulated or pelletized activated carbon present inside of the of sealable container and contained in a liquid permeable enclosure fabricated from a liquid permeable material and present inside of the sealable container; and

sealing the sealable container.

19. The method according to claim 18 , wherein the liquid permeable enclosure is joined to the container.

20. A device for use in disposing an amount of a pharmaceutical composition, the device comprising:

a sealable container configured as a pouch and dimensioned to accommodate the pharmaceutical composition; and

an amount of an inactivating substance present inside of the sealable container, wherein the inactivating substance is not present in a free-flowing form and is adhered to an inner surface of the container as a layer on the inner surface of the container.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2016
From: TEIKOKU PHARMA USA, INC.
To: VERDE ENVIRONMENTAL TECHNOLOGIES, INC.
Reel/Frame 039563/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2012
From: FOWLER, WILLIAM; ANDERSON, CLAYTON; ANDERSON, CARTER
To: TEIKOKU PHARMA USA, INC.
Reel/Frame 029206/0631 →